UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.027

Sortiert nach

Recurrent TERT promoter mutations identified in a large-scale study of multiple tumour types are associated with increased TERT expression and telomerase activation

European journal of cancer (1990), 2015-05, Vol.51 (8), p.969-976

2015

Volltextzugriff (PDF)

Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study

The lancet oncology, 2018-01, Vol.19 (1), p.139-148

2018

Volltextzugriff (PDF)

Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Treatment of Stage IIIA-N2 EGFR -Mutant Non-Small-Cell Lung Cancer (EMERGING-CTONG 1103): A Randomized Phase II Study

Journal of clinical oncology, 2019-09, Vol.37 (25), p.2235-2245

2019

Volltextzugriff (PDF)

Adjacent Segment Disease after Instrumented Fusion for Adult Lumbar Spondylolisthesis: Incidence and Risk Factors

Clinical neurology and neurosurgery, 2017-05, Vol.156, p.29-34

2017

Volltextzugriff (PDF)

Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial

Journal of clinical oncology, 2021-03, Vol.39 (7), p.713-722

2021

Volltextzugriff (PDF)

Distribution and prognosis of uncommon metastases from non-small cell lung cancer

BMC cancer, 2016-02, Vol.16 (147), p.149-149, Article 149

2016

Volltextzugriff (PDF)

The changes of immunoglobulin G N-glycosylation in blood lipids and dyslipidaemia

Journal of translational medicine, 2018-08, Vol.16 (1), p.235-235, Article 235

2018

Volltextzugriff (PDF)

Risk factors for bone cement leakage in percutaneous vertebroplasty: a retrospective study of four hundred and eighty five patients

International orthopaedics, 2016-06, Vol.40 (6), p.1205-1210

2016

Volltextzugriff (PDF)

Acquired MET Y1248H and D1246N Mutations Mediate Resistance to MET Inhibitors in Non-Small Cell Lung Cancer

Clinical cancer research, 2017-08, Vol.23 (16), p.4929-4937

2017

Volltextzugriff (PDF)

Identification of enriched driver gene alterations in subgroups of non-small cell lung cancer patients based on histology and smoking status

PloS one, 2012-06, Vol.7 (6), p.e40109-e40109

2012

Volltextzugriff (PDF)

EGFR Mutation Heterogeneity and the Mixed Response to EGFR Tyrosine Kinase Inhibitors of Lung Adenocarcinomas

The oncologist (Dayton, Ohio), 2012-07, Vol.17 (7), p.978-985

2012

Volltextzugriff (PDF)

Upregulated expression of ADAM17 is a prognostic marker for patients with gastric cancer

Annals of surgery, 2012-12, Vol.256 (6), p.1014-1022

2012

Volltextzugriff (PDF)

Crizotinib in advanced non-small-cell lung cancer with concomitant ALK rearrangement and c-Met overexpression

BMC cancer, 2018-11, Vol.18 (1), p.1171-1171, Article 1171

2018

Volltextzugriff (PDF)

Detection of Driver and Resistance Mutations in Leptomeningeal Metastases of NSCLC by Next-Generation Sequencing of Cerebrospinal Fluid Circulating Tumor Cells

Clinical cancer research, 2017-09, Vol.23 (18), p.5480-5488

2017

Volltextzugriff (PDF)

Challenge of parents caring for children or adolescents with early‐stage schizophrenia in China: A qualitative study

Perspectives in psychiatric care, 2020-10, Vol.56 (4), p.777-784

2020

Volltextzugriff (PDF)

Predictors for Poor Outcomes After Percutaneous Endoscopic Lumbar Discectomy: A Retrospective Study of 241 Patients

World neurosurgery, 2019-06, Vol.126, p.e422-e431

2019

Volltextzugriff (PDF)

Clinicopathological features and resistance mechanisms in HIP1‐ALK‐rearranged lung cancer: A multicenter study

Genes chromosomes & cancer, 2022-04, Vol.61 (4), p.177-186

2022

Volltextzugriff (PDF)

Relative Abundance of EGFR Mutations Predicts Benefit From Gefitinib Treatment for Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2011-08, Vol.29 (24), p.3316-3321

2011

Volltextzugriff (PDF)

Plasma and tumor levels of Linc-pint are diagnostic and prognostic biomarkers for pancreatic cancer

Oncotarget, 2016-11, Vol.7 (44), p.71773-71781

2016

Volltextzugriff (PDF)

Application of indocyanine green fluorescence for precision sublobar resection

Thoracic cancer, 2019-04, Vol.10 (4), p.624-630

2019

Volltextzugriff (PDF)

Prevalence and associated knowledge of hepatitis B infection among healthcare workers in Freetown, Sierra Leone

BMC infectious diseases, 2018-07, Vol.18 (1), p.315-315, Article 315

2018

Volltextzugriff (PDF)

SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients

Clinical cancer research, 2010-01, Vol.16 (1), p.260-268

2010

Volltextzugriff (PDF)

The Unique Spatial-Temporal Treatment Failure Patterns of Adjuvant Gefitinib Therapy: A Post Hoc Analysis of the ADJUVANT Trial (CTONG 1104)

Journal of thoracic oncology, 2019-03, Vol.14 (3), p.503-512

2019

Volltextzugriff (PDF)

MiR-125b promotes cell migration and invasion by targeting PPP1CA-Rb signal pathways in gastric cancer, resulting in a poor prognosis

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2015-10, Vol.18 (4), p.729-739

2015

Volltextzugriff (PDF)

Disparity in clinical outcomes between pure and combined pulmonary large-cell neuroendocrine carcinoma: A multi-center retrospective study

Lung cancer (Amsterdam, Netherlands), 2020-01, Vol.139, p.118-123

2020

Volltextzugriff (PDF)

1 – 25 von 2.027

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.436)
Mit Volltextzugriff
(1.503)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Recurrent TERT promoter mutations identified in a large-scale study of multiple tumour types are associated with increased TERT expression and telomerase activation

Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study

Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Treatment of Stage IIIA-N2 EGFR -Mutant Non-Small-Cell Lung Cancer (EMERGING-CTONG 1103): A Randomized Phase II Study

Adjacent Segment Disease after Instrumented Fusion for Adult Lumbar Spondylolisthesis: Incidence and Risk Factors

Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial

Distribution and prognosis of uncommon metastases from non-small cell lung cancer

The changes of immunoglobulin G N-glycosylation in blood lipids and dyslipidaemia

Risk factors for bone cement leakage in percutaneous vertebroplasty: a retrospective study of four hundred and eighty five patients

Acquired MET Y1248H and D1246N Mutations Mediate Resistance to MET Inhibitors in Non-Small Cell Lung Cancer

Identification of enriched driver gene alterations in subgroups of non-small cell lung cancer patients based on histology and smoking status

EGFR Mutation Heterogeneity and the Mixed Response to EGFR Tyrosine Kinase Inhibitors of Lung Adenocarcinomas

Upregulated expression of ADAM17 is a prognostic marker for patients with gastric cancer

Crizotinib in advanced non-small-cell lung cancer with concomitant ALK rearrangement and c-Met overexpression

Detection of Driver and Resistance Mutations in Leptomeningeal Metastases of NSCLC by Next-Generation Sequencing of Cerebrospinal Fluid Circulating Tumor Cells

Challenge of parents caring for children or adolescents with early‐stage schizophrenia in China: A qualitative study

Predictors for Poor Outcomes After Percutaneous Endoscopic Lumbar Discectomy: A Retrospective Study of 241 Patients

Clinicopathological features and resistance mechanisms in HIP1‐ALK‐rearranged lung cancer: A multicenter study

Relative Abundance of EGFR Mutations Predicts Benefit From Gefitinib Treatment for Advanced Non–Small-Cell Lung Cancer

Plasma and tumor levels of Linc-pint are diagnostic and prognostic biomarkers for pancreatic cancer

Application of indocyanine green fluorescence for precision sublobar resection

Prevalence and associated knowledge of hepatitis B infection among healthcare workers in Freetown, Sierra Leone

SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients

The Unique Spatial-Temporal Treatment Failure Patterns of Adjuvant Gefitinib Therapy: A Post Hoc Analysis of the ADJUVANT Trial (CTONG 1104)

MiR-125b promotes cell migration and invasion by targeting PPP1CA-Rb signal pathways in gastric cancer, resulting in a poor prognosis

Disparity in clinical outcomes between pure and combined pulmonary large-cell neuroendocrine carcinoma: A multi-center retrospective study

Aktive Filter

Suchergebnisse filtern